一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Scientific Reports >>article
Scientific Reports

Scientific Reports

IF: 3.8
Download PDF

Reversine exhibits antineoplastic activity in JAK2V617F-positive myeloproliferative neoplasms

Published:9 July 2019 DOI: 10.1038/s41598-019-46163-2 PMID: 31289316
Keli Lima, Jorge Antonio Elias Godoy Carlos, Raquel de Melo Alves-Paiva, Hugo Passos Vicari, Fábio Pires de Souza Santos, Nelson Hamerschlak, Leticia Veras Costa-Lotufo, Fabiola Traina, Jo?o Agostinho Machado-Neto

Abstract

JAK2/STAT signaling participates in the Ph-negative myeloproliferative neoplasms (MPN) pathophysiology and has been targeted by ruxolitinib, a JAK1/2 inhibitor. In the present study, the impact of ruxolitinib treatment on cytoskeleton-related genes expression was explored. In SET2 cells, AURKA and AURKB expression/activity were downregulated in a dose- and time-dependent manner by ruxolitinib. Reversine, a multikinase inhibitor selective for aurora kinases, reduced cell viability in a dose- and/or time-dependent manner in JAK2V617F cells. Reversine significantly increased apoptosis and mitotic catastrophe, and reduced cell proliferation and clonogenic capacity in SET2 and HEL cells. In the molecular scenario, reversine induced DNA damage and apoptosis markers, as well as, reduced AURKA and AURKB expression/activity. In SET2 cells, reversine modulated the expression of 32 out of 84 apoptosis-related genes investigated, including downregulation of antiapoptotic (BCL2, BCL2L1, and BIRC5) and upregulation of proapoptotic (BIK, BINP3, and BNIP3L) genes. Synergism experiments indicated that low dose of reversine had a potentiating effect under ruxolitinib treatment at low doses in SET2 cells. In summary, our exploratory study establishes new targets, related to the regulation of the cellular cytoskeleton, for potential pharmacological intervention in MPN. These findings indicate that AURKA and AURKB participate in the JAK2/STAT signaling pathway and contribute to the MPN phenotype.

Substances (5)

Materials Related products
Procduct Name CAS Molecular Formula Supplier Price
REVERSINE 656820-32-5 C21H27N7O 178 suppliers $12.00-$1802.00
REVERSINE 656820-32-5 C21H27N7O 178 suppliers $12.00-$1802.00
REVERSINE 656820-32-5 C21H27N7O 178 suppliers $12.00-$1802.00
REVERSINE 656820-32-5 C21H27N7O 178 suppliers $12.00-$1802.00

Similar articles

IF:4.8

Exploring Trimethyl-Phosphate-Based Electrolytes without a Carbonyl Group for Li-Rich Layered Oxide Positive Electrodes in Lithium-Ion Batteries

The Journal of Physical Chemistry Letters Zezhao Liu, Zhishan Liu,etc Published: 1 December 2022
IF:3.9

Antibacterial activity of chlorhexidine

Journal of Hospital Infection A.D. Russell , M.J. Day,etc Published: 1 December 1993
杨浦区| 九龙坡区| 札达县| 资源县| 临沂市| 滁州市| 五家渠市| 信宜市| 光山县| 陵水| 含山县| 革吉县| 永泰县| 全州县| 遂溪县| 镇远县| 通道| 长治市| 清丰县| 武乡县| 临漳县| 兴隆县| 武威市| 皋兰县| 开江县| 祁阳县| 浠水县| 吕梁市| 同仁县| 新邵县| 唐海县| 武隆县| 通榆县| 米泉市| 获嘉县| 河东区| 安塞县| 调兵山市| 高雄县| 永新县| 个旧市|